Vericel (VCEL) Live Share Price, Invest From India

Vericel Stock Performance

as on October 1, 2026 at 6:13 am IST

Day's Low
Day's High
$39.82
Day's Price Range
$40.97
$40.20
0.95%
Downside
1.92%
Upside
52 Week's Low
52 Week's High
$28.95
52-Week Price Range
$49.32
$40.20
27.99%
Downside
22.69%
Upside

Vericel share price movements today

Previous Close: $40.61
Open: $40.80
Volume: 327.5K
Market Cap: $2.1B
Day's Low - High: $39.82 - $40.97
52 Week Low - High: $28.95 - $49.32

Vericel Historical Returns

1 Month Return: -0.83 %
3 Month Return: -8.72 %
1 Year Return: + 29.04 %
3 Year Return: + 21.15 %
5 Year Return: -16.78 %

Vericel Stock Fundamentals & Key Indicators

Check Vericel market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.19%

PE Ratio (TTM)

83.83

Industry PE ratio

-12.23

PEG Ratio

0.35

EBITDA

38.5M

Revenue (TTM)

306.3M

Profit Margin

74.56%

Return On Equity TTM

6.91%

Vericel vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vericel with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Vericel	StrongBuy	$2.1B	-16.78%	83.83	74.56%	0.00%
Revolution Medicines	StrongBuy	$43.2B	643.29%	-22.77	0.00%	0.00%
Moderna	Neutral	$78.8B	-47.13%	-24.72	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$133.4B	189.75%	30.38	86.04%	0.00%
Regeneron	Buy	$81.1B	24.01%	17.96	84.86%	0.49%

Stock Returns calculator for Vericel Stock including INR - Dollar returns

The Vericel stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Vericel investment value today

Current value as on today

₹1,37,790

Returns

₹37,790

(+37.79%)

Returns from Vericel Stock

₹27,741 (+27.74%)

Dollar Impact

₹10,049 (+10.05%)

Analyst Recommendation on Vericel Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Vericel. Average target price of $60.57

Vericel Share Price Target

Get share price movements and forecasts by analysts on Vericel.

What analysts predicted

33.63%UPSIDE

Target Price

$60.57

Current Price

$40.2

Analyzed by

3 Analysts

High

$72

Target

$60.57

Low

$58

Vericel target price $60.57, a slight upside of 33.63% compared to current price of $40.2. According to 3 analysts rating.

Indian Investors' Interest in Vericel Stock

Search interest for Vericel Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 1, 2026 to October 1, 2026

Change:26% versus previous 30 day period

Vericel Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	51	52	57	75	52	63	67	92	68	77
Gross Profit	35	36	41	58	36	46	49	73	49	56
Operating Income	-5	-6	-2	18	-12	-2	3	22	-8	0
EBITDA	-2	-3	0	21	-8	2	8	27	-2	5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	1	1	2	2	2	3	3	3
Income Before Tax	-3	-4	0	19	-11	0	5	24	-6	2
Income Tax Expense	-	-	-	0	-	-	-	0	-	-
Net Income	-3	-4	0	19	-11	0	5	23	-6	2
Net Profit Margin	68.94%	69.50%	71.93%	77.61%	68.96%	73.71%	73.46%	78.70%	72.00%	72.82%

Vericel Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	63	90	117	124	156	164	197	237	276
Gross Profit	33	58	80	84	106	109	135	172	205
Operating Income	-14	-3	-11	2	-7	-17	-6	4	11
EBITDA	-14	-4	-7	5	-4	-11	2	16	30
Interest Expense	1	1	0	0	0	0	0	0	1
Depreciation	1	1	1	2	2	3	4	5	11
Income Before Tax	-17	-8	-9	3	-7	-15	-2	10	17
Income Tax Expense	-	-	-	0	0	0	0	0	0
Net Income	-17	-8	-9	2	-7	-16	-3	10	16
Net Profit Margin	52.52%	64.60%	68.12%	67.83%	67.88%	66.80%	68.64%	72.55%	74.42%

Vericel Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-3	-4	0	19	-11	0	5	23	-6	6
Operating Cash Flow	7	18	10	22	6	8	22	15	16	16
Investing Cash Flow	-25	-17	-21	-14	-15	-9	-3	-16	-4	-2
Financing Cash Flow	2	4	5	7	3	1	1	1	-2	1
Change in Cash	-16	5	-5	14	-5	0	19	0	9	14

Vericel Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-17	-8	-9	2	-7	-16	-3	10	16
Operating Cash Flow	-13	0	-7	17	29	17	35	58	51
Investing Cash Flow	-1	-67	10	-17	-3	-36	-3	-79	-43
Financing Cash Flow	18	58	5	6	9	1	3	19	7
Change in Cash	3	-8	8	6	34	-17	35	-1	15

Global Institutional Holdings in Vericel

Check out the Institutions with significant holdings in Vericel.

Funds	Holdings
iShares	11.87%
Vanguard	5.80%
VANGUARD INDEX FUNDS	4.25%
SPDR	4.15%
Conestoga Funds	3.06%

See all

Insights on Vericel

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 68.42M → 77.45M (in $), with an average increase of 11.7% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, VCEL stock has moved up by 4.7%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -6.30M → 2.20M (in $), with an average increase of 385.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 658.7%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 97.0% return, outperforming this stock by 75.8%

About Vericel

Vericel Corporation operates as a biopharmaceutical firm that has reached the commercialization phase, specializing in the research, development, production, and distribution of cell-based treatments. Its primary therapeutic areas are sports medicine and critical burn care across the United States. The company's product lineup includes MACI, an autologous cellularized scaffold employed for mending symptomatic, full-thickness cartilage damage in the knee, and Epicel, a permanent skin replacement designated as a humanitarian use device for treating deep-dermal or full-thickness burns in both adults and children. Additionally, Vericel is progressing NexoBrid, an orphan biological product currently in the registration phase, which aims to remove eschar from deep partial-thickness or full-thickness thermal burns in adults. Established in 1989 under its former name, Aastrom Biosciences, Inc., the company is headquartered in Cambridge, Massachusetts.

Organisation	Vericel
Headquarters	25 Blue Sky Drive, Burlington, MA, 01803, US
Industry	Biotechnology
CEO	Dominick C. Colangelo

Key Management of Vericel

Name	Title
Mr. Joseph Anthony Mara Jr.	CFO & Treasurer
Mr. Sean C. Flynn	Chief Legal Officer
Mr. Jonathan D. Siegal	Principal Accounting Officer, VP & Corporate Controller
Mr. Eric Burns	Vice President of Finance & Investor Relations
Mr. Roland DeAngelis	Chief Marketing Officer
Mr. Patrick J. Fowler	Senior Vice President of Corporate Development & Strategy
Mr. Mike Gilligan	Senior Vice President of Sales
Mr. Dominick C. Colangelo Esq.	CEO, President & Director
Mr. Michael Halpin	Chief Operating Officer
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.	Chief Medical Officer

FAQs

What is Vericel share price today?

Vericel share price today is $40.20 as on October 1, 2026 at 12:43 am IST. Vericel share today touched a day high of $40.97 and a low of $39.82.

What is the 52 week high and 52 week low for Vericel share?

Vericel share touched a 52 week high of $49.32 on July 30, 2026 and a 52 week low of $28.95 on March 27, 2026. Vericel stock price today i.e. October 1, 2026 at 12:43 am IST is trending at $40.20,which is 18.49% down from its 52 week high and 38.86% up from its 52 week low.

What is Vericel's market capitalisation today?

Vericel market capitalisation is $0.00T as on October 1, 2026 at 12:43 am IST.

How to invest in Vericel Stock (VCEL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Vericel on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Vericel Stock (VCEL) from India?

Indian investors can start investing in Vericel (VCEL) shares with as little as ₹95.83000183105469 or $1 (as of October 1, 2026 at 12:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Vericel stock (as per the Rupee-Dollar exchange rate as on October 1, 2026 at 12:43 am IST). Based on Vericel share’s latest price of $40.20 as on October 1, 2026 at 12:43 am IST, you will get 0.2488 shares of Vericel. Learn more about fractional shares .

What are the returns that Vericel has given to Indian investors in the last 5 years?

Vericel stock has given -16.78% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?